Answer
The safety and efficacy of pegunigalsidase alfa have not been evaluated in patients older than 65 years.
Sources for this answer
- Elfabrio 2 mg/mL concentrate for solution for infusionChiesi Limited · emc · SmPC §4.2 Posology and method of administration · Version 3Document updated
Sources checked